10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 2 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $111,540 | -70.5% | 2,704 | -60.0% | 0.00% | -76.9% |
Q2 2023 | $377,590 | +100056.5% | 6,762 | +0.1% | 0.01% | +8.3% |
Q1 2023 | $377 | +255.7% | 6,758 | +132.9% | 0.01% | +200.0% |
Q4 2022 | $106 | -100.0% | 2,902 | -85.0% | 0.00% | -55.6% |
Q3 2022 | $551,000 | -30.1% | 19,347 | +11.2% | 0.01% | -50.0% |
Q2 2022 | $788,000 | +35.2% | 17,398 | +127.2% | 0.02% | +200.0% |
Q1 2022 | $583,000 | -3.2% | 7,657 | +89.7% | 0.01% | -40.0% |
Q4 2021 | $602,000 | +58.4% | 4,037 | +54.4% | 0.01% | 0.0% |
Q3 2021 | $380,000 | -86.4% | 2,615 | -81.7% | 0.01% | -86.3% |
Q2 2021 | $2,795,000 | -1.8% | 14,273 | -9.2% | 0.07% | +52.1% |
Q1 2021 | $2,846,000 | +466.9% | 15,725 | +343.5% | 0.05% | +220.0% |
Q4 2020 | $502,000 | +1631.0% | 3,546 | +1408.9% | 0.02% | – |
Q3 2020 | $29,000 | -63.3% | 235 | -73.4% | 0.00% | -100.0% |
Q2 2020 | $79,000 | -80.3% | 883 | -83.2% | 0.00% | -90.9% |
Q4 2019 | $401,000 | +60.4% | 5,263 | +6.3% | 0.03% | +94.1% |
Q3 2019 | $250,000 | – | 4,952 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |